FDA Drug InformationПотвърден профил

@FDA_Drug_Info

Receive the latest drug information from the US FDA. Contact us at 1.855.543.3784 or druginfo@fda.hhs.gov. Privacy Policy - .

Silver Spring
fda.gov/AboutDDI
Регистриран през юли 2009 г.
535 Снимки и видеоклипове Снимки и видеоклипове

Туитове

Блокираш @FDA_Drug_Info

Наистина ли искаш да видиш тези туитове? Това няма да разблокира @FDA_Drug_Info

  1. преди 5 часа

    At ? Have questions about ? Stop by Exhibit #1051 to pick up materials and learn more!

    1 ретуит
  2. преди 7 часа

    New Drug Trials Snapshot available for Mepsevii (vestronidase alfa-vjbk): . Access PI at: .

    3 харесва
  3. 4.12

    We're in Orlando for ! Stop by Exhibit #1051 and learn how to stay up to date with critical information that impacts the public health!

    3 ретуита 5 харесва
  4. 4.12

    New Drug Trials Snapshot available for Prevymis (letermovir): .

    3 ретуита 4 харесва
  5. 4.12

    How does protect ? Take this training course to learn about the drug regulatory process & earn FREE CE!

    9 ретуита 4 харесва
  6. 1.12

    new biosimilar for the treatment of certain breast and stomach cancers: .

    2 replies 36 ретуита 32 харесва
  7. 1.12

    Learn how to participate in the 2018 Experiential Learning Site Visit Program for FDA’s Office of Pharmaceutical Quality (OPQ) Staff: .

    3 ретуита 3 харесва
  8. 1.12

    new medication-assisted treatment option for opioid use disorder: .

    9 replies 36 ретуита 21 харесва
  9. ретуитна
    30.11

    working to help stabilize medical products industry in Puerto Rico; taking steps with drug makers to mitigate IV saline fluid and amino acids for injection shortages:

    4 replies 14 ретуита 9 харесва
  10. ретуитна
    30.11

    Statement by FDA Commissioner on the agency’s efforts to help stabilize the medical products industry in Puerto Rico and the steps being taken with drug manufacturers to mitigate the IV saline fluid and the amino acids for injection shortages

    4 ретуита 2 харесва
  11. 29.11

    first generic version of Prezista (darunavir ethanolate): .

    2 replies 6 ретуита 11 харесва
  12. ретуитна
    29.11

    FDA formed a Nicotine Steering Committee as part of its comprehensive tobacco plan. It will focus on the agency’s evaluation of, and the science behind, nicotine replacement therapy products for helping smokers quit.

    21 replies 43 ретуита 37 харесва
  13. 29.11

    New Chronicles ! PDUFA VI: A Time for Change: .

    2 ретуита
  14. 29.11

    Learn about what's new in PDUFA VI in the latest Chronicles - PDUFA VI: A Time for Change. .

    1 reply 3 ретуита 1 харесват
  15. 28.11

    Do work the same as brand-name medicines? Yes—find out why.

    5 replies 24 ретуита 20 харесва
  16. 28.11

    Register for the 10th Annual Sentinel Initiative Public Workshop on February 7-8, 2018 to learn about Sentinel tools and capabilities: .

    1 reply 4 ретуита 3 харесва
  17. 28.11

    We’re in National Harbor for ! Stop by booth #622 & learn how to stay up to date with important drug safety information.

    3 ретуита 6 харесва
  18. 28.11

    Watch the newest video FDA’s Role in Foreign Drug Manufacturing!

    3 replies 5 ретуита 6 харесва
  19. 27.11

    Learn about The FDA’s Sentinel Initiative in the latest CDER Conversation: .

    6 ретуита 6 харесва
  20. 21.11

    NEW Orange Book Updates! Search results and drug listings will show patent submission dates, where available: .

    1 reply 16 ретуита 15 харесва

Потребителят @FDA_Drug_Info още не е туитвал.

Изглежда зареждането отнема известно време.

Twitter може да е претоварен или да изпитва моментно затруднение. Опитай отново или виж Twitter Status за повече информация.

    Може също да харесаш

    ·